People · Operator
Named in public records as an officer, director or promoter · active 2015–2025 · Other, Biotechnology
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Recompose, PBC | — | Other | Series B | $24.7M | $92.2M | 2025 |
| Ntxbio, Llc | — | Biotechnology | Pre-Seed | $1.9M | $50.5M | 2015 |
| Immunological Solutions, Inc. | — | Other | Pre-Seed | $157K | $3.6M | 2019 |
| Innate Immunity Llc | — | Biotechnology | Pre-Seed | $130K | $6.5M | 2020 |
Michelle Miller at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Michelle Miller on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Stuart Schoenmann | 1 | 4 |
| Karyn Barsa | 1 | 2 |
| Leslie Christian | 1 | 1 |
| Katrina Spade | 1 | 1 |
| Robert Schapira | 1 | 1 |
| Sara Moorhead | 1 | 1 |
| Sara Moorehead | 1 | 1 |
| Matthew Ennis | 1 | 1 |
| Goutam Gupta | 1 | 1 |
| Lavi Malhotra | 1 | 1 |
| Tanya Marsh | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.